Shree Pacetronix Stock Screener | Share Price & Fundamental Analysis
SHREEPAC
Medical Equipment
Share Price BSE
₹123.15
▲
2.20 (1.82%)
Track Shree Pacetronix share price live with TickJournal's free stock screener.
Analyze Shree Pacetronix share price history trends and compare 52-week high low
levels.
Calculate SHREEPAC stock fair value using fundamental analysis and view live share price charts.
Determine Shree Pacetronix share intrinsic value and compare it with current SHREEPAC share price.
Record your Shree Pacetronix trades in TickJournal's free trading journal and track your portfolio performance.
Shree Pacetronix Market Cap
₹44.39 Cr.
SHREEPAC P/E Ratio (TTM)
18.06
EPS (TTM)
₹2.08
Dividend Yield
-
Debt to Equity
0.35
SHREEPAC 52 Week High
₹279.70
Shree Pacetronix 52 Week Low
₹62.31
Operating Margin
23.00%
Profit Margin
-
SHREEPAC Revenue (TTM)
₹4.00
EBITDA
₹1.00
Net Income
-
Total Assets
₹23.00
Total Equity
₹14.00
Shree Pacetronix Share Price History - Stock Screener Chart
Screen SHREEPAC historical share price movements with interactive charts. Analyze price trends and patterns.
Shree Pacetronix Company Profile - Fundamental Screener
Screen Shree Pacetronix company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for SHREEPAC shares.
Sector
Healthcare
Industry
Medical Equipment
Sub-Sector
Medical Equipment
Segment
E
ISIN
INE847D01010
Shree Pacetronix Balance Sheet Screener
Screen SHREEPAC balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Total Assets | 23 | 22 | 17 | 12 | 11 | 11 | 11 | 10 | 9 | 9 |
| Current Assets | 17 | 15 | 11 | 7 | 6 | 6 | 7 | 6 | 6 | 6 |
| Fixed Assets | 4 | 4 | 3 | 3 | 3 | 3 | 2 | 2 | 2 | 3 |
| Liabilities | ||||||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 0 | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 0 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||||
| Total Equity | 14 | 13 | 10 | 6 | 6 | 6 | 5 | 5 | 5 | 5 |
| Share Capital | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 | 4 |
| Reserves & Surplus | 10 | 9 | 6 | 3 | 2 | 2 | 2 | 2 | 1 | 2 |
Shree Pacetronix Income Statement Screener - Profit & Revenue Analysis
Screen Shree Pacetronix income statement and profit fundamentals.
Analyze SHREEPAC quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Shree Pacetronix share price evaluation.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec | 2023-Mar | 2023-Jun | 2023-Sept | 2023-Dec | 2022-Mar | 2022-Jun | 2022-Sept |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 4 | 5 | 7 | 4 | 7 | 5 | 4 | 4 | 8 | 6 | 5 | 4 | 2 | 3 | 4 |
| Expenses | 3 | 4 | 5 | 4 | 4 | 4 | 4 | 4 | 5 | 5 | 4 | 4 | 2 | 3 | 4 |
| EBITDA | 1 | 1 | 2 | 0 | 3 | 1 | 0 | 0 | 3 | 1 | 1 | 1 | 1 | 1 | 1 |
| Operating Profit % | 23.00% | 22.00% | 31.00% | 10.00% | 37.00% | 16.00% | 10.00% | 4.00% | 39.00% | 23.00% | 22.00% | 20.00% | 25.00% | 21.00% | 16.00% |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 1 | 1 | 2 | 0 | 2 | 1 | 0 | 0 | 3 | 1 | 1 | 1 | 0 | 1 | 0 |
| Tax | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit | 0 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 2 | 1 | 1 | 0 | 0 | 0 | 0 |
| EPS | 1.26 | 1.85 | 3.64 | 0.16 | 3.98 | 1.03 | 0.09 | -0.31 | 5.44 | 2.40 | 1.85 | 1.10 | 0.84 | 1.12 | 0.79 |
Shree Pacetronix Cash Flow Screener - Liquidity Fundamentals
Screen SHREEPAC cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 0 | 0 | 2 | 2 | 1 | 2 | 0 | 1 | 0 | 1 |
| Investing Activities | 0 | -2 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | 0 |
| Financing Activities | 0 | 2 | -1 | 0 | 0 | -1 | 0 | -1 | 0 | -1 |
| Net Cash Flow | 0 | 0 | -1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Shree Pacetronix Shareholding Pattern Screener
See Shree Pacetronix shareholding pattern with promoter, FII, and DII holdings.
Check Shree Pacetronix promoter holding and ownership changes for SHREEPAC on TickJournal.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Nov | 2025-Dec | 2024-Mar | 2024-Jun | 2024-Sept |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 24.25% | 24.25% | 24.25% | 25.80% | 25.80% | 24.25% | 24.25% | 24.25% |
| FII Holding | 0.00% | 0.00% | 0.14% | 0.14% | 0.14% | 0.00% | 0.00% | 0.00% |
| DII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 45.80% | 45.19% | 46.87% | 46.29% | 45.91% | 44.72% | 45.17% | 45.14% |
| Other Holding | 29.95% | 30.56% | 28.74% | 27.78% | 28.15% | 31.04% | 30.58% | 30.61% |
| Shareholder Count | 6,981 | 6,972 | 6,665 | 6,564 | 6,528 | 6,580 | 6,689 | 6,992 |
Shree Pacetronix Share Dividend Screener - Share Yield Analysis
Check Shree Pacetronix dividend history with payout and yield data.
View Shree Pacetronix dividend details including ex-dates and amounts for SHREEPAC stock.
Shree Pacetronix Stock Index Membership
See which indices include Shree Pacetronix stock.
Check SHREEPAC index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
Shree Pacetronix Market Events Screener - Corporate Actions
Get Shree Pacetronix corporate actions including splits, bonuses, and buybacks.
Check Shree Pacetronix stock events that may affect SHREEPAC share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Annual General Meeting | NA | 54.66% | ||
| Annual General Meeting | NA | -3.24% | ||
| 2026-02-13 | 2026-02-13 | Quarterly Result Announcement | NA | 15.05% |
| 2025-11-01 | 2025-11-01 | Quarterly Result Announcement | NA | 8.30% |
| 2025-08-07 | 2025-08-07 | Quarterly Result Announcement | NA | 61.37% |
| 2025-05-30 | 2025-05-30 | Quarterly Result Announcement | NA | 11.90% |
| 2025-01-28 | 2025-01-28 | Quarterly Result Announcement | NA | -14.66% |
| 2024-10-19 | 2024-10-19 | Quarterly Result Announcement | NA | 2.14% |
Shree Pacetronix Competitors Screener - Peer Comparison
Screen SHREEPAC competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Poly Medicure | 13,011 | 38.44 | 1,759 | 22.62% | 339 | 39.68 |
| Tarsons Products | 1,034 | 50.12 | 408 | 32.64% | 30 | 46.81 |
| Laxmi Dental | 993 | 41.39 | 242 | 24.12% | 25 | 39.54 |
| Osel Devices | 880 | 42.98 | 187 | 40.62% | 20 | 50.07 |
| Vasa Denticity | 730 | 55.89 | 173 | % | 15 | 28.69 |
| Fabtech Technologies | 699 | 19.11 | 336 | 45.66% | 47 | 50.92 |
| Prevest Denpro | 488 | 25.12 | 67 | 13.15% | 18 | 32.28 |
| Aprameya Engineering | 473 | 26.76 | 136 | 107.77% | 16 | 55.67 |
| Hemant Surgical Industries | 338 | 41.01 | 112 | % | 8 | 37.09 |
| Nureca | 263 | 23.43 | 122 | 19.24% | 1 | 37.54 |
Shree Pacetronix Company Announcements - News Screener
Screen SHREEPAC latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-03-02 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2026-02-14 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2026-02-13 | Submission Of Unaudited Financial Results (Standalone And Consolidated) Along With Limited Review Report For The Quarter And Nine Months Ended 31St December 2025. | View |
| 2026-02-13 | Board Meeting Outcome for Outcome Of The Board Meeting Held On Friday 13Th February 2026. | View |
| 2026-02-04 | Board Meeting Intimation for Prior Intimation Of The BM 2025-26 Of The Company Under Reg 29 (1) And (2) Of SEBI (LODR) Reg 2015 To Inter-Alia Consider And Approve The Standalone And Consolidated Unaudited FR For The Quarter Ended 31.12.2025 | View |
| 2026-01-22 | Intimation Of Receipt Of Trading Approval For 75150 Equity Shares Of Rs.10/- Each Issued At Premium Of Rs. 71/- Bearing Distinctive Numbers From 3599401 To 3674550 Issued To Promoter On A Preferential Basis | View |
| 2026-01-13 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | View |
| 2026-01-07 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | View |
| 2025-12-30 | Intimation Of Approval Received For Listing Of 75150 Equity Shares Of Rs. 10/- Each Allotted On Preferential Basis | View |
| 2025-12-26 | Closure of Trading Window | View |
| 2025-11-27 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-11-27 | Post Offer Advertisement | View |
| 2025-11-17 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | View |
| 2025-11-14 | Disclosure Under Regulation 29(2) Of The SEBI (Substantial Acquisition Of Shares And Takeovers) Regulations 2011 ("SEBI (SAST) Regulations") | View |
| 2025-11-14 | Announcement under Regulation 30 (LODR)-Allotment | View |
| 2025-11-14 | Board Meeting Outcome for Outcome Of Meeting Of Board Of Directors Of The Company Held On Today I.E. Friday 14Th November2025 W.R.T. Allotment Of Equity Shares On Preferential Basis. | View |
| 2025-11-11 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-11-11 | Updates on Open Offer | View |
| 2025-11-02 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-11-01 | Submission Of Unaudited Financial Results (Standalone And Consolidated) Along With Limited Review Report For The Quarter And Half Year Ended 30Th September 2025. | View |